Erwinase and Kidrolase are oncology drugs used in the treatment of acute lymphoblastic leukemia.
Janet Greeson, CEO of Samaritan, said: “We are always enthusiastic about growing our marketing and sales arm and increasing our sales revenues and think Erwinase and Kidrolase can play an important role as much needed cancer drugs in Samaritan’s strategy to become cash flow positive by 2009.